Anil Shinde

Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease

Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Shinde et al. · European Journal of Medicinal Chemistry · 2015 · 59 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1<i>H</i>-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT₆) Receptor Antagonist for Potential Treatment of Alzheimer’s Disease

Ramakrishna Nirogi, Anil Shinde, Rama Sastry Kambhampati et al. · Journal of Medicinal Chemistry · 2017 · 46 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization

Ramakrishna Nirogi, Renny Abraham, Vijay Benade et al. · Behavioural Pharmacology · 2018 · 36 citations

Medicine, Neuroscience, Pharmacology +17

Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study

Ramakrishna Nirogi, John R. Ieni, Vinod Goyal et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2022 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT₄ Receptor Partial Agonists

Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Shinde et al. · Journal of Medicinal Chemistry · 2018 · 29 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17